OCTREOTID Labatec sol inj 0.5 mg/ml 5 amp 1 ml
7680632410038
CH-63241
H01CB02
07.16.2.
Reimbursement limitations:
SANDOSTATIN
Tumeurs du système endocrine gastroentéropancréatique.
Acromégalie qui ne réagit pas ou pas suffisamment à d'autres …
1 / 3
google
Details
- Product number
- 6324104
- CPT
- -
- Packaging group
- 5 x 1 ml
- Unit
- Ampulle(n)
- Composition
- octreotidum 0.5 mg ut, octreotidi acetas, glycinum, mannitolum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Octreotid Labatec 0,5 mg/mL, Solution pour injection
Solution pour injection
5 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 239.35
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2014
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 63241
- Drug name
- Octreotid Labatec, Solution pour injection
- Galenic form
- LSINJ
- ATC Code
- H01CB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 16/04/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OCTREOTID Labatec sol inj 0.5 mg/ml 5 amp 1 ml
- Description (DE)
- OCTREOTID Labatec Inj Lös 0.5 mg/ml 5 Amp 1 ml
- Market launch
- 16/04/2014
- Narcotic (BTM)
- No